These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1912990)

  • 61. A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.
    Pratt WE; Clissold KA; Lin P; Cain AE; Ciesinski AF; Hopkins TR; Ilesanmi AO; Kelly EA; Pierce-Messick Z; Powell DS; Rosner IA
    Brain Res; 2016 Oct; 1648(Pt A):54-68. PubMed ID: 27431937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Directly Observable Behavioral Effects of Lorcaserin in Rats.
    Serafine KM; Rice KC; France CP
    J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serotonin and the regulation of mammalian energy balance.
    Donovan MH; Tecott LH
    Front Neurosci; 2013; 7():36. PubMed ID: 23543912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Central nervous control of energy and glucose balance: focus on the central melanocortin system.
    Xu Y; Elmquist JK; Fukuda M
    Ann N Y Acad Sci; 2011 Dec; 1243():1-14. PubMed ID: 22211889
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serotonergic anti-obesity agents: past experience and future prospects.
    Halford JC; Boyland EJ; Lawton CL; Blundell JE; Harrold JA
    Drugs; 2011 Dec; 71(17):2247-55. PubMed ID: 22085383
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of serotonergic drugs to treat obesity--is there any hope?
    Bello NT; Liang NC
    Drug Des Devel Ther; 2011 Feb; 5():95-109. PubMed ID: 21448447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia.
    Lam DD; Zhou L; Vegge A; Xiu PY; Christensen BT; Osundiji MA; Yueh CY; Evans ML; Heisler LK
    Behav Brain Res; 2009 Jan; 196(1):139-43. PubMed ID: 18762217
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.
    Lam DD; Przydzial MJ; Ridley SH; Yeo GS; Rochford JJ; O'Rahilly S; Heisler LK
    Endocrinology; 2008 Mar; 149(3):1323-8. PubMed ID: 18039773
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacological profile of the 5-HT(2C) receptor agonist WAY-163909; therapeutic potential in multiple indications.
    Dunlop J; Marquis KL; Lim HK; Leung L; Kao J; Cheesman C; Rosenzweig-Lipson S
    CNS Drug Rev; 2006; 12(3-4):167-77. PubMed ID: 17227285
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.
    Halford JC; Harrold JA; Boyland EJ; Lawton CL; Blundell JE
    Drugs; 2007; 67(1):27-55. PubMed ID: 17209663
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?
    Meneses A
    Cell Mol Neurobiol; 2002 Dec; 22(5-6):675-88. PubMed ID: 12585687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
    Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats.
    Mazzola-Pomietto P; Aulakh CS; Murphy DL
    Psychopharmacology (Berl); 1995 Oct; 121(4):488-93. PubMed ID: 8619014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
    Dursun SM; Handley SL
    Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
    Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
    [TBL] [Abstract][Full Text] [Related]  

  • 77. m-Chlorophenylpiperazine decreases food intake in a test meal.
    Walsh AE; Smith KA; Oldman AD; Williams C; Goodall EM; Cowen PJ
    Psychopharmacology (Berl); 1994 Sep; 116(1):120-2. PubMed ID: 7862925
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
    Terry P; Katz JL
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):328-33. PubMed ID: 7862841
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.
    Kennedy AJ; Gibson EL; O'Connell MT; Curzon G
    Psychopharmacology (Berl); 1993; 113(2):262-8. PubMed ID: 7855192
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.
    Kennett GA; Pittaway K; Blackburn TP
    Psychopharmacology (Berl); 1994 Feb; 114(1):90-6. PubMed ID: 7846211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.